SA’s Aspen signs deal to package and sell J&J COVID vaccine
SOUTH AFRICAN drugmaker Aspen Pharmacare concluded an agreement with Johnson & Johnson to package, sell and distribute the American group's COVID-19 vaccines under its own brand in Africa. In November Aspen entered into talks with J&J for a licensing deal that would give it freedom to sell and distribute the vaccine under its own brand. The agreement also allows Aspen to "discuss the expansion of the agreement to include any new versions of the drug substance, such as those developed for new variants or a different formulation for administration as a booster", Aspen said in a statement. J&J had contracted Aspen…